ContractContribution Agreement • January 27th, 2015 • Novartis Ag • Pharmaceutical preparations
Confidential portions of this exhibit have been omitted and filed separately with the Securities and Exchange Commission
21 November 2014 GLAXOSMITHKLINE PLC and NOVARTIS AGSale and Purchase Agreement • January 27th, 2015 • Novartis Ag • Pharmaceutical preparations
No Brand name Active Ingredient Product Description Marketing Authorisation details (includes all countries that have product approval; NOTE; for products with multiple indications, some countries may not have yet have approval for all indications) Product Expansion Applications ( includes only those submitted or currently under regulatory review) ATC Code Dosage
FIRST AMENDMENT TO STOCK AND ASSET PURCHASE AGREEMENTStock and Asset Purchase Agreement • January 27th, 2015 • Novartis Ag • Pharmaceutical preparations • New York
THIS STOCK AND ASSET PURCHASE AGREEMENT (as it may be amended or supplemented from time to time in accordance with the terms hereof, this Agreement), dated as of April 22, 2014, is entered into by and between Novartis AG, a company incorporated under the laws of Switzerland (the Seller), and Eli Lilly and Company, a corporation organized under the laws of Indiana (the Purchaser; each of the Purchaser and the Seller is a Party and together are the Parties).
Dated 26 October 2014 NOVARTIS AG and CSL LIMITED SHARE AND BUSINESS SALE AGREEMENT relating to the Flu GroupShare and Business Sale Agreement • January 27th, 2015 • Novartis Ag • Pharmaceutical preparations
DEED OF AMENDMENT AND RESTATEMENT relating to the IMPLEMENTATION AGREEMENT dated 22 April 2014Implementation Agreement • January 27th, 2015 • Novartis Ag • Pharmaceutical preparations
